Jim Simons
TTOO

Jim Simons’s T2 Biosystems, Inc TTOO Stock Holding History

Jim Simons’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-447
Closed -$2.66M – 3943
2021
Q2 		$2.66M Buy
447
+312
+231% +$2.01M ﹤0.01% 2055
2021
Q1 		$1.1M Buy
+135
New +$1.43M ﹤0.01% 2571
2019
Q1 		– Sell
-33
Closed -$502K – 3759
2018
Q4 		$502K Sell
33
-39
-54% -$916K ﹤0.01% 2860
2018
Q3 		$2.68M Sell
72
-92
-56% -$3.03M ﹤0.01% 2139
2018
Q2 		$6.36M Buy
164
+130
+382% +$4.93M 0.01% 1624
2018
Q1 		$1.1M Buy
34
+17
+100% +$458K ﹤0.01% 2620
2017
Q4 		$344K Buy
17
+7
+70% +$145K ﹤0.01% 2984
2017
Q3 		$204K Buy
+10
New +$186K ﹤0.01% 2996
2016
Q1 		– Sell
-4
Closed -$243K – 3569
2015
Q4 		$243K Hold
4
– – ﹤0.01% 2944
2015
Q3 		$153K Sell
4
-1
-20% -$66.4K ﹤0.01% 2945
2015
Q2 		$383K Sell
5
-4
-44% -$347K ﹤0.01% 2800
2015
Q1 		$692K Buy
+9
New +$836K ﹤0.01% 2476

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jim Simons's TTOO Position: Q3 2021 in Review

Jim Simons sold out of T2 Biosystems, Inc (TTOO) in Q3 2021, closing a stake of 447 shares — an estimated $2.66M sold.

Jim Simons first reported a position in TTOO in Q1 2015 and held it in 12 quarters. The position peaked at $6.36M in Q2 2018. 73 funds tracked by Wall St. Rank hold TTOO as of Q3 2021.

  • Jim Simons reported no remaining T2 Biosystems, Inc position as of Q3 2021 after selling out during the quarter.
  • Jim Simons sold 447 T2 Biosystems, Inc shares in Q3 2021, an estimated $2.66M.
  • Jim Simons first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 12 quarters.
  • Jim Simons's T2 Biosystems, Inc position peaked at $6.36M in Q2 2018.
  • 73 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2021.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.